Future Perspectives: Key Trends Shaping the Cholesterol Test Market up to 2030

A Look Ahead at the Cholesterol Test Market's Future Growth

The cholesterol test market is set for remarkable expansion in the coming years, driven by technological advancements and changing healthcare priorities. With rising awareness about cardiovascular health and the growing importance of early disease detection, this market is poised to capture significant opportunities. Let's explore the market size projections, key players, emerging trends, and detailed segment breakdowns shaping this sector's trajectory through 2030.

Download a free sample of the cholesterol test market report:
https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Cholesterol Test Market Size and Expected Growth Through 2030
The size of the cholesterol test market is forecasted to reach $15.25 billion by 2030, growing at a healthy compound annual growth rate (CAGR) of 9.0%. This anticipated growth is primarily fueled by increasing demand for diagnostic tools that enable self-monitoring, a stronger emphasis on early detection of diseases, expansion in remote patient testing solutions, and higher integration of digital health technologies. Additionally, personalized healthcare diagnostics are being adopted more widely. Key trends expected to impact this growth include the rising popularity of home-based cholesterol testing kits, greater demand for point-of-care lipid testing devices, increased use of multi-parameter lipid panels, expansion of preventive cardiovascular screening programs, and a focus on delivering rapid, accurate test results.

Leading Corporations Driving the Cholesterol Test Market
Several influential companies are key players in the cholesterol test market, including F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, and Diazyme Laboratories Inc.
In a noteworthy development, January 2023 saw South Korea-based diagnostics reagent company SD Biosensor, Inc., along with SJL Partners, a private equity firm, acquire Meridian Bioscience, Inc. for $1.53 billion. This acquisition aims to enhance Meridian Bioscience's ability to serve the growing diagnostics demand and develop innovative solutions by leveraging SD Biosensor's expertise. Meridian Bioscience, a US-based life sciences firm, specializes in manufacturing and marketing novel diagnostic devices focused on cholesterol and cardiac health.

A Look Ahead at the Cholesterol Test Market's Future Growth

The cholesterol test market is set for remarkable expansion in the coming years, driven by technological advancements and changing healthcare priorities. With rising awareness about cardiovascular health and the growing importance of early disease detection, this market is poised to capture significant opportunities. Let's explore the market size projections, key players, emerging trends, and detailed segment breakdowns shaping this sector's trajectory through 2030.

Download a free sample of the cholesterol test market report:
https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
Cholesterol Test Market Size and Expected Growth Through 2030
The size of the cholesterol test market is forecasted to reach $15.25 billion by 2030, growing at a healthy compound annual growth rate (CAGR) of 9.0%. This anticipated growth is primarily fueled by increasing demand for diagnostic tools that enable self-monitoring, a stronger emphasis on early detection of diseases, expansion in remote patient testing solutions, and higher integration of digital health technologies. Additionally, personalized healthcare diagnostics are being adopted more widely. Key trends expected to impact this growth include the rising popularity of home-based cholesterol testing kits, greater demand for point-of-care lipid testing devices, increased use of multi-parameter lipid panels, expansion of preventive cardiovascular screening programs, and a focus on delivering rapid, accurate test results.

Leading Corporations Driving the Cholesterol Test Market
Several influential companies are key players in the cholesterol test market, including F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, and Diazyme Laboratories Inc.
In a noteworthy development, January 2023 saw South Korea-based diagnostics reagent company SD Biosensor, Inc., along with SJL Partners, a private equity firm, acquire Meridian Bioscience, Inc. for $1.53 billion. This acquisition aims to enhance Meridian Bioscience's ability to serve the growing diagnostics demand and develop innovative solutions by leveraging SD Biosensor's expertise. Meridian Bioscience, a US-based life sciences firm, specializes in manufacturing and marketing novel diagnostic devices focused on cholesterol and cardiac health.

Key Trends Positively Influencing Cholesterol Test Market Growth
Companies in the diagnostic sensor market are increasingly focusing on innovative solutions like multi-parameter sensors that improve diagnostic precision, broaden applications, and enable real-time health monitoring. Multi-parameter sensors combine multiple sensing technologies into compact devices capable of simultaneously measuring various physical or chemical parameters.
For example, in May 2025, the Interuniversity Microelectronics Centre in Belgium unveiled an advanced, highly miniaturized ingestible sensor designed for gut health monitoring. This capsule measures just 2.1 cm long and 0.75 cm in diameter-about three times smaller than conventional endoscopic capsules-making it easier to swallow and more comfortable for patients. The device integrates sensors for oxidation-reduction potential (ORP), pH, and temperature, providing real-time biochemical data from the gastrointestinal tract every 20 seconds throughout digestion. Powered by low-energy electronics and a small battery, the sensor features wireless data transmission and a biocompatible casing, enabling continuous, noninvasive internal monitoring. This technology holds great promise for early diagnosis of inflammation, oxidative stress, and microbiome imbalances.

How the Cholesterol Test Market Is Segmented
This report categorizes the cholesterol test market into several segments to better understand its scope:
1) By Product Type: Test Kits, Test Strips, Other Product Types
2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides or Very Low-Density Lipoprotein (VLDL) Cholesterol Test
3) By Distribution Channel: Over The Counter, Prescription Based
4) By End User: Hospitals, Diagnostic Centers, Other End Users
Further subsegments include:
- Test Kits: Home Testing Kits, Laboratory Testing Kits
- Test Strips: Disposable Test Strips, Multi-Use Test Strips
- Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents and Calibration Solutions

This detailed segmentation helps highlight the diversity within the cholesterol test market and the various avenues through which products reach end users.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.